NCT07020923Phase 2Active not recruiting

Monthly Dosing of Atacicept in IgAN

Study sponsor: Vera Therapeutics, Inc. · VERA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-22Actual
Enrollment · participants90Estimated
Source updated2026-11-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2026. After: 22 Sep 2026.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source